Stepping down from high dose fluticasone/salmeterol to extrafine BDP/F in asthma is cost-effective

Paggiaro P, Patel S, Nicolini G, Pradelli L, Zaniolo O, Papi A. – Respir Med 2013; 107(10): 1531-7

A cost-minimization analysis of combination therapy in hypertension: fixed-dose vs extemporary combinations

Bellone M, Sbarra P. – Farmeconomia. Health economics and therapeutic pathways 2013; 14(4): 153-160

ISPOR 2013: what’s new and what’s old?

Zaniolo O, Povero M. – Farmeconomia. Health economics and therapeutic pathways 2013; 14(4): 151-152

First-line HIV treatment: evaluation of backbone choice and its budget impact

Zaniolo O, Povero M, Bonfanti P, Borderi M, Medaglia M. – Farmeconomia. Health economics and therapeutic pathways 2013; 14(2): 75-87

Costs of treatment of haemophilia a in Italy: comparison of the use of plasma-derived and recombinant FVIII using a discrete event simulation (DES) model

Eandi M, Pradelli L, Povero M. – Farmeconomia. Health economics and therapeutic pathways 2013; 14(2): 51-74